MENU
+Compare
ALZN
Stock ticker: NASDAQ
AS OF
Dec 18, 01:44 PM (EDT)
Price
$1.30
Change
+$0.01 (+0.78%)
Capitalization
7.01M

ALZN Alzamend Neuro Inc. Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for ALZN with price predictions
Dec 17, 2024

ALZN's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ALZN turned positive on December 09, 2024. Looking at past instances where ALZN's MACD turned positive, the stock continued to rise in of 29 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALZN's RSI Oscillator exited the oversold zone, of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 46 cases where ALZN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on ALZN as a result. In of 54 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALZN advanced for three days, in of 143 cases, the price rose further within the following month. The odds of a continued upward trend are .

ALZN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALZN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ALZN entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.867) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). ALZN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (260.687).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ALZN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALZN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ALZN is expected to report earnings to fall 91.67% to -5 cents per share on January 03

Alzamend Neuro Inc. ALZN Stock Earnings Reports
Q4'23
Est.
$-0.05
Q3'23
Missed
by $0.56
Q2'23
Missed
by $0.42
Q1'23
Missed
by $0.86
Q4'22
Beat
by $0.01
The last earnings report on September 12 showed earnings per share of -60 cents, missing the estimate of -3 cents. With 36.44K shares outstanding, the current market capitalization sits at 7.01M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3480 Peachtree Road NE
Phone
+1 844 722-6333
Employees
7
Web
https://www.alzamend.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNSP0.110.01
+8.74%
CNS Pharmaceuticals Inc
INSM73.850.46
+0.63%
Insmed
LRN107.60-1.34
-1.23%
Stride
PBYI2.92-0.08
-2.67%
Puma Biotechnology
ECX1.82-0.12
-6.19%
ECARX Holdings

ALZN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
+5.74%
SRPT - ALZN
49%
Loosely correlated
-0.81%
NCNA - ALZN
45%
Loosely correlated
+1.19%
VRAX - ALZN
41%
Loosely correlated
+10.39%
SNSE - ALZN
41%
Loosely correlated
+11.97%
BPMUF - ALZN
36%
Loosely correlated
N/A
More